Michel Zwaan, MD, PhD

Articles by Michel Zwaan, MD, PhD

Michel Zwaan, MD, PhDAcute Lymphoblastic Leukemia | April 22, 2024
A phase II study presented at ASPHO 2024 evaluated revumenib in KMT2A-rearranged ALL and AML.